Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because you know what we are going to say — that oh-so-familiar routine of deadlines, meetings, Skype calls, and the like has predictably returned with a vengeance. But what can you do? The world keeps spinning, sometimes faster than we would like. So to cope, yes, we are firing up the coffee kettle to brew cups of stimulation. Our choice today is maple pecan. Feel free to join us. Meanwhile, here are a few tidbits to get you started. Hope all goes well today and, as always, please do keep in touch.
Nearly eight in 10 Americans say the cost of prescription drugs is unreasonable, but with such broad and bipartisan support, why do the odds look grim for Congress to pass significant drug pricing legislation this year? Kaiser Health News asks. Whether the issue is sharing the credit for a legislative victory with the other party or running afoul of the powerful drug maker lobby, neither Democrats nor Republicans are sure the benefits are worth the risks.